Analytical and Clinical Validation Requirements for Next Generation

Поділитися
Вставка
  • Опубліковано 26 січ 2020
  • Presented By: Ryan S. Robetorye, M.D., Ph.D.
    Speaker Biography: Dr. Ryan S. Robetorye received his M.D. and Ph.D. degrees from Baylor College of Medicine in Houston, Texas. He is board certified in Clinical Pathology, Hematology, and Molecular Genetic Pathology and currently works as a Consultant at the Mayo Clinic in Phoenix, Arizona.
    Webinar: Analytical and Clinical Validation Requirements for Next Generation Sequencing Laboratory-Developed Tests
    Webinar Abstract: Next generation sequencing (NGS) has revolutionized molecular diagnostic testing. It is important to note that, as with many molecular diagnostic tests currently in clinical use, there are very few FDA-approved or FDA-cleared NGS assays, and thus analytical and clinical assay validation of laboratory-developed tests (LDTs) is essential to the application of NGS technology for clinical diagnostic testing.
    Earn PACE Credits:
    1. Make sure you’re a registered member of LabRoots (www.LabRoots.com)
    2. Watch the webinar on UA-cam or on the LabRoots Website (www.LabRoots.com)
    3. Click Here to get your PACE credits (Expiration date - 10/17/2021): www.labroots.com/credit/pace-...
    LabRoots on Social:
    Facebook: / labrootsinc
    Twitter: / labroots
    LinkedIn: / labroots
    Instagram: / labrootsinc
    Pinterest: / labroots
    SnapChat: labroots_inc
  • Наука та технологія

КОМЕНТАРІ •